Elimination of Kupffer cells and administration of protease inhibitor improve graft viability and prevent reperfusion injury in NHBD.
Tsukamoto
S
S
Second Department of Surgery, Tohoku University School of Medicine, Sendai, Japan.
Ohkohchi
N
N
Orii
T
T
Fukumori
T
T
Asakura
T
T
Takayama
J
J
Kato
H
H
Satomi
S
S
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D004002:Clodronic Acid / Q000008:administration & dosage / Q000494:pharmacology*; D004337:Drug Carriers; D004734:Energy Metabolism; D006085:Graft Survival / Q000187:drug effects / Q000502:physiology*; D006323:Heart Arrest; D007728:Kupffer Cells / Q000166:cytology* / Q000187:drug effects; D008081:Liposomes; D016031:Liver Transplantation / Q000502:physiology*; D011480:Protease Inhibitors / Q000494:pharmacology*; D015427:Reperfusion Injury / Q000517:prevention & control*; D013552:Swine; D014019:Tissue Donors
D004337:Drug Carriers; D008081:Liposomes; D011480:Protease Inhibitors; D004002:Clodronic Acid; D000255:Adenosine Triphosphate